Drug elimination in chronic liver diseases

Journal of Hepatology, Supplement

Volumn 26, Issue 2, 1997, Pages 63-72

  Huet, Pierre Michel ^a   Villeneuve, Jean Pierre ^a   Fenyves, Daphna ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Cirrhosis; Drug elimination; Liver diseases

Indexed keywords

BENZODIAZEPINE; FUROSEMIDE; LIDOCAINE; PHENAZONE; PROPRANOLOL; TRIAZOLAM;

CHRONIC LIVER DISEASE; CONFERENCE PAPER; DRUG ELIMINATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER CIRRHOSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030916234     PISSN: 01695185     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0168-8278(97)80498-9     Document Type: Conference Paper

References (40)

1. Rappaport AM. The microcirculatory hepatic unit. Microvasc Res 1973; 6: 212-22.
2. Goresky CA, Huet PM, Villeneuve JP. Blood-tissue exchange and blood flow in the liver. In: Zakim D, Boyer TD, eds. Hepatology, A Text Book of Liver Diseases. Philadelphia: W.B. Saunders, 1982; 32-63.
3. Wisse E, De Zanger RB, Jacobs R, McCuskey RS. Scanning electron microscopic observation on the structure of portal veins, sinusoids and central veins in rat liver. Scan Electron Microsc 1983; 3: 1441-52.
4. Horn T, Henriksen JH, Christoffersen P. The sinusoidal lin-ing cells in "normal" human liver. A scanning electron microscopic investigation. Liver 1986; 6: 98-110.
5. Vidai-Vanaclocha F, Barbera-Guillem E. Fenestration patterns in endothelial cells of rat liver sinusoids. J Ultrastruc Res 1985; 90: 115-23.
6. Villeneuve JP, Huet PM. Microcirculation abnormalities in liver diseases. Hepatology 1987; 7: 186-7.
7. Jones AL, Schmucker DL. Concepts of liver structure as related to function. Gastroenterology 1977; 73: 833-51.
8. Motta P, Muto M, Fujita T. The liver. In: An Atlas of Scanning Electron Microscopy. Tokyo: Igaky-Shoin, 1978.
9. Wilkinson GR, Shand DG. A physiological approach to hepatic drug clearance. Clin Pharmacol Ther 1975; 18: 377-90.
10. Kernhäuser DM, Wood AJJ, Vestal RE, Wilkinson GR, Branch RA, Shand DG. Biological determinants of propranolol disposition in man. Clin Pharmacol Ther 1978; 23:165-74.
11. Huet PM, LeLorier J. Effects of smoking and chronic hepatitis B on lidocaine and indocyanine green kinetics. Clin Pharmacol Ther 1980; 28: 208-15.
12. Mitra SK. Hepatic vascular changes in human and experimental cirrhosis. J Pathol Bacteriol 1966; 92: 405-15.
13. Popper H, Elias H, Petty DE. Vascular pattern of the cirrhotic liver. Am J Clin Pathol 1952; 22: 717-29.
14. Huet PM, Pomier-Layrargues G, Villeneuve JP, Varin F, Viallet A. Intrahepatic circulation in liver disease. Semin Liver Dis 1986; 6: 277-86.
15. Huet PM, Villeneuve JP, Pomier Layrargues G, Marleau D. Hepatic circulation in cirrhosis. Clin Gastroenterol 1985; 14: 155-68.
16. Villeneuve JP, Huet PM, Gariépy L, Fenyves D, Willems B, Côté J, Lapointe R, Marleau D. Isolated perfused cirrhotic human liver obtained from liver transplant patients: a feasibility study. Hepatology 1990; 12: 257-63.
17. Schaffner F, Popper H. Capillarization of hepatic sinusoids. Gastroenterology 1963; 44: 239-42.
18. Huet PM, Goresky CA, Villeneuve JP, Marleau D, Lough JO. Assessment of liver microcirculation in human cirrhosis. J Clin Invest 1982; 70: 1235-44.
19. Philips MJ, Steiner JW. Electron microscopy of liver cells in cirrhotic nodules. Am J Pathol 1965; 46: 985-1005.
20. Eguchi T, Ikejiri N, Kawaguchi M, Miyahodo V, Abe H, Tanikawa K. Scanning and transmission electron microcopic observation of human and rat liver sinusoid in liver cirrhrosis. J Clin Electron Microsc 1975; 8: 5-6.
21. Henriksen J, Horn T, Christoffersen P. The blood-lymph barrier in the liver. A review based on morphological and functional concepts of normal and cirrhotic liver. Liver 1984; 4: 221-32.
22. Horn T, Christoffersen P, Henriksen J. Alcoholic liver injury: defenestration in non cirrhotic livers - a scanning electron microscopy. Hepatology 1987; 7: 77-82.
23. Mak KM, Lieber CJ. Alterations in endothelial fenestrations in liver sinusoids of baboons fed alcohol: a scanning electron microscopy study. Hepatology 1984; 4: 386-91.
24. Varin F, Huet PM. Hepatic microcirculation in the perfused cirrhotic rat liver. J Clin Invest 1985; 76: 1904-12.
25. Villeneuve JP, Dagenais M, Huet PM, Roy A, Lapointe R, Marleau D. The hepatic microcirculation in the isolated perfused human liver. Submitted to Hepatology.
26. Wilson RA, Hart FE, Hew JT. Comparison of in vivo and in vitro drug metabolism in experimental hepatic injury in the rat. Gastroenterology 1979; 76: 697-703.
27. Lauterburg BH, Bircher J. Expiration measurement of maxi-mal aminopyrine demethylation in vivo: effect of phénobarbital, partial hepatectomy, portocaval shunt and bile duct ligation in thé rat. J Pharmacol Exp Ther 1976; 196: 501-9.
28. Zysset T. Aminopyrine N-demethylation by rats with liver cirrhosis. Gastroenterology 1987; 93: 719-26.
29. Fenyves D, Gariépy L, Villeneuve JP. Clearance by the liver in cirrhosis. I. Relationship between propranolol metabolism in vitro and its extraction by the perfused liver in the rat. Hepatology 1993; 17: 301-6.
30. Gariépy L, Fenyves D, Kassissia I, Villeneuve JP. Clearance by the liver in cirrhosis. II. Characterization of propranolol uptake with the multiple-indicator dilution technique. Hepatology 1993; 18: 823-31.
31. Villeneuve JP, Thibeault MJ, Ampelas M, Fortunet-Fouin H, Lamarre L, Côté J, Pomier Layrargues G, Huet PM. Drug disposition in patients with HBsAg-positive chronic liver disease. Dig Dis Sci 1987; 32: 710-4.
32. Branch RA, Shand DG. Propranolol disposition in chronic liver disease: a physiological approach. Clin Pharmacokinet 1976; 1: 264-79.
33. Huet PM, Villeneuve JP. Determinants of drug disposition in patients with cirrhosis. Hepatology 1983; 3: 913-8.
34. Pomier-Layrargues G, Huet PM, Villeneuve JP, Marleau D. Effect of portacaval shunt on drug disposition in patients with cirrhosis. Gastroenterology 1986; 91: 163-7.
35. Kraus JW, Desmond PV, Marshall JP, Johnson RF, Schenker S, Wilkinson GR. Effect of aging and liver disease on disposition of lorazepam. Clin Pharmacol Ther 1978; 24: 411-9.
36. Shull HJ, Wilkinson GR, Johnson R, Schenker S. Normal disposition of oxazepam in acute viral hepatitis and cirrhosis. Ann Intern Med 1976; 84: 420-5.
37. Pugh RWH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1983; 60: 646-9.
38. Branch RA. Drugs as indicators of hepatic function. Hepatology 1982; 2: 97-105.
39. Bakti G, Fisch HV, Karlaganis G, Minder C, Bircher J. Mechanism of the excessive sedative response of cirrhotics to benzodiazapines: model experiments with triazolam. Hepatology 1987; 7: 629-38.
40. Villeneuve JP, Verbeeck RK, Wilkinson GR, Branch RA. Furosemide kinetics and dynamics in patients with cirrhosis. Clin Pharmacol Ther 1986; 40: 14-20.